- Vaccination rates continue to decline which has led many states to try new strategies to persuade unvaccinated people to get vaccinated. President Biden announced that the federal government will also use incentives to help reach his administration’s goal to get over 70% of American adults to receive their first shot before July 4.
- The Biden Administration announced how it plans to share excess vaccine and how it will distribute the first 25 million COVID-19 vaccine doses.
- The new White House science adviser wants to have a vaccine ready to fight the next pandemic in just about 100 days after recognizing a potential viral outbreak.
- About 150 fully vaccinated adults will participate in an NIH-backed trial that will evaluate outcomes after mixing different vaccines for booster doses. For example, this study will evaluate if a person who received one type of vaccine (e.g. Pfizer) can receive a booster dose from a different manufacturer (e.g. Moderna or Johnson and Johnson).
White House and Federal Agencies
- Vaccination rates continue to decline, which has led many states to try new strategies to persuade unvaccinated people to get vaccinated. President Biden announced that the federal government will also use incentives to help reach his administration’s goal to get over 70% of American adults to receive their first shot before July 4.
- A dozen states have vaccinated at least 70% of their adult populations.
- President Biden unveiled his budget proposal for 2022 on Friday, which includes major increases for scientific agencies and research programs. The National Institute of Health (NIH) and the Centers for Disease Control and Prevention (CDC) would each receive more than 20% increases in their annual budgets.
- The Biden Administration previously stated it plans to share excess vaccine doses with other countries. This week, the administration announced how it will distribute the first 25 million COVID-19 vaccine doses.
- Medicare spending on COVID-19-related care for fee-for-service beneficiaries reached $6.3 billion from April through December 2020, while the mean hospitalization costs per case totaled $21,752.
- The new White House science adviser wants to have a vaccine ready to fight the next pandemic in just about 100 days after recognizing a potential viral outbreak.
Centers for Disease Control and Prevention (CDC) Updates
- The CDC published the following reports and websites updates:
- Overall US COVID-19 Vaccine Distribution and Administration Update as of Thu, 03 Jun 2021 06:00:00 EST
- Interim Public Health Recommendations for Fully Vaccinated People
- Cases in the U.S.
- CDC COVID-19 Data
- COVID-19 Vaccines that Require 2 Shots
- CDC’s COVID-19 Weekly Partner Calls
- Workplaces and Businesses
- Information About Johnson & Johnson’s Janssen COVID-19 Vaccine
- COVID-19 Travel Recommendations by Country
- U.S. COVID-19 Vaccination Program: Vaccine Channel Portfolio by Jurisdiction
- COVID Data Tracker Recent Updates – 2021-05-27 – The Healthcare Personnel tab now shows trends in cases and deaths among healthcare personnel by week
- Clinical Considerations: Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults
- Health Equity in Action
- Choosing Safer Activities
- COVID-19 Hospitalization and Death by Race/Ethnicity
- Possible Side Effects After Getting a COVID-19 Vaccine
- Reporting COVID-19 Vaccination Demographic Data
Economy, Vaccines, Testing and Treatment
- More than 60% of U.S. adults have gotten at least one dose of the COVID-19 vaccine, and overall rates could reach 70% in the next few months, according to research from the Kaiser Family Foundation.
- COVID-19 vaccination continues to lag among vulnerable populations despite their eligibility for vaccines.
- The CDC is predicting that COVID-19 cases, hospitalizations and deaths will decrease over the next four weeks.
- Moderna has asked the FDA for full approval of its coronavirus vaccine in people 18 and older.
- The heads of four major global agencies, including the WHO and the International Monetary Fund (IMF), are calling for world leaders to invest $50 billion towards ending the pandemic.
- New reporting highlights inconsistent state-level data collection for vaccination rates by race and ethnicity.
- NIH Director Dr. Francis Collins is highlighting two new studies that show mRNA vaccines for COVID-19 “appear to be completely safe for pregnant women.”
- Biomedical Advanced Research and Development Authority (BARDA) is launching a new program to work with venture capital companies to help bring to market breakthrough technologies in preparation for the next pandemic. This program will provide $50 million over five years with the potential for up to $500 million over 10 years.
- The pandemic moratorium on evictions will continue after a federal appeals court denied a legal challenge to lift the moratorium on evictions. A federal court recently ruled against the moratorium but stayed the decision from taking effect pending an appeal.
- About 150 fully vaccinated adults will participate in an NIH-backed trial that will evaluate outcomes after mixing different vaccines for booster doses. For example, this study will evaluate if a person who received one type of vaccine (e.g. Pfizer) can receive a booster dose from a different manufacturer (e.g. Moderna or Johnson and Johnson).
